Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies
Authors
Keywords
-
Journal
THROMBOSIS AND HAEMOSTASIS
Volume 111, Issue 06, Pages 1167-1176
Publisher
Schattauer GmbH
Online
2014-04-01
DOI
10.1160/th14-03-0231
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patient’s values and preferences for stroke prevention in atrial fibrillation: balancing stroke and bleeding risk with oral anticoagulation
- (2014) Gregory Lip et al. THROMBOSIS AND HAEMOSTASIS
- Stepwise Screening of Atrial Fibrillation in a 75-Year-Old Population
- (2013) Johan Engdahl et al. CIRCULATION
- Management of Patients With Atrial Fibrillation (Compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS Recommendations)
- (2013) Jeffrey L. Anderson et al. CIRCULATION
- Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin
- (2013) Martin Zalesak et al.
- iPhone ECG application for community screening to detect silent atrial fibrillation: A novel technology to prevent stroke
- (2013) Jerrett K. Lau et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- ADVERSE PROGNOSIS OF ASYMPTOMATIC ATRIAL FIBRILLATION DETECTED INCIDENTALLY: A CASE FOR SCREENING
- (2013) S. Ben Freedman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fog on the Crystal Ball? Missing Atrial Fibrillation in Forecasting the Future of Stroke
- (2013) Lis Neubeck et al. STROKE
- Adelaide Stroke Incidence Study
- (2013) James M. Leyden et al. STROKE
- Forecasting the Future of Stroke in the United States: A Policy Statement From the American Heart Association and American Stroke Association
- (2013) B. Ovbiagele et al. STROKE
- Atrial Fibrillation, Stroke Risk, and Warfarin Therapy Revisited
- (2013) Staffan Björck et al. STROKE
- Screening to identify unknown atrial fibrillation
- (2013) Nicole Lowres et al. THROMBOSIS AND HAEMOSTASIS
- Evaluation of patients’ attitudes towards stroke prevention and bleeding risk in atrial fibrillation
- (2013) Steffi Regpala et al. THROMBOSIS AND HAEMOSTASIS
- Assessing cardiovascular risk in regional areas: the Healthy Hearts – Beyond City Limits program
- (2012) Melinda J Carrington et al. BMC HEALTH SERVICES RESEARCH
- Barriers to Warfarin Use for Stroke Prevention in Patients With Atrial Fibrillation in Hong Kong
- (2012) Vivian W. Y. Lee et al. CLINICAL CARDIOLOGY
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPEAN HEART JOURNAL
- Screening for atrial fibrillation above age 65 detects an asymptomatic subset at high risk of stroke
- (2012) Bishoy Deif et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Sex Differences in Stroke Risk Among Older Patients With Recently Diagnosed Atrial Fibrillation
- (2012) Cynthia A. Jackevicius JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Subclinical Atrial Fibrillation and the Risk of Stroke
- (2012) Jeff S. Healey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada
- (2012) Michael Sharma et al. THROMBOSIS AND HAEMOSTASIS
- Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation
- (2012) Ron Pisters et al. THROMBOSIS AND HAEMOSTASIS
- 173 Silent atrial fibrillation in olmsted county: A community-based study
- (2011) T.S. Tsang et al. CANADIAN JOURNAL OF CARDIOLOGY
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study
- (2011) Amitava Banerjee et al. THROMBOSIS AND HAEMOSTASIS
- An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality
- (2010) E. Aliot et al. EUROPACE
- The health loss from ischemic stroke and intracerebral hemorrhage: evidence from the North East Melbourne Stroke Incidence Study (NEMESIS)
- (2010) Dominique A Cadilhac et al. Health and Quality of Life Outcomes
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now